Practical Reviews

Mental Health Black Box Warning Removed for Bupropion, Varenicline


In December 2016, the Food and Drug Administration (FDA) updated the drug safety communication regarding use of bupropion (Zyban ® ) and varenicline (Chantix ® ) medications for tobacco dependence treatment. After reviewing data from a recent large clinical trial, the FDA determined that the “…risk of serious side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) is lower than previously suspected.” Subsequently, the more...
ABSTRACT VIEW
To view this content, you must be a logged in subscriber to PracticalReviews.com.
Please Login to view this content.